- Evidence of any unstable or clinically significant, hematopoietic, malignant, cardiovascular, hepatic, renal, neurologic, psychiatric, or autoimmune disorder/condition/disease that in the opinion of the Investigator could place the subject at increased risk of complications, interfere with study participation, or confound any of the study objectives;